Now I did take some poster's advice and accelerated my next script to late December so I am currently well stocked. I am wondering if when my script comes due again for refilling I should let them go ahead and give me the GV. Then I could tell them it made me sick and I need my brand back..
raf; this just illustrates why Amarin management has to go. Doesn't matter if it is a whole new BOD and CEO. How many times have the shareholders been disappointed in Amarins Inaction to things most people would not stand for. How hard would it be to put out a PR on just the Inactive ingredients on what Lizzy has provided and compare it against what the Vascepa Bottle label? It's hard to refute facts. Corporations do it all the time, just look at FORD and GM? The toolbox trick by GM probably sold an additional 20,000 pickup trucks.
How hard would it be to have sponsored/supported Marjac at the EPADI Appeal? Especially when the EPADI effort was group funded?
This Amarin team has to go, the sooner the better.
Raf, even if results show the generic is very different, what changes? Studies have shown the Lovaza is useless and it hasn't slowed prescriptions of Lovaza and fake Lovaza. Unless you can show generic V is dangerous, nothing changes.
I guess we'll just have to agree to disagree. "Court of public opinion"? where has that got us with the reduce-it and evaporate studies? You don't think there will be people jumping out of the woodwork discrediting an AMRN funded study to discredit its competition? And I agree it doesn't need to be published, but it does need to be public to be legitimate.
...... I do appreciate all you do however - just disagree on the value of this.